Welcome to our dedicated page for Orion Acquisition news (Ticker: OHPAU), a resource for investors and traders seeking the latest updates and insights on Orion Acquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Orion Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Orion Acquisition's position in the market.
Orion Acquisition Corp. (Nasdaq: OHPAU) announced that starting April 22, 2021, holders of its initial public offering (IPO) units can separate the Class A common stock and warrants for trading. The IPO, consisting of 41,400,000 units, was completed on March 4, 2021. Credit Suisse Securities served as the book-running manager for the offering. Separated shares will trade under symbols OHPA and OHPAW on Nasdaq. The announcement does not constitute an offer to sell or solicit securities. The company is focused on mergers and acquisitions in the healthcare sector.
Orion Acquisition Corp. announced the successful closure of its upsized initial public offering (IPO) of 41,400,000 units at $10.00 each, generating total gross proceeds of $414 million. Each unit comprises one share of Class A common stock and one-quarter of a warrant. The IPO proceeds are intended for future business combinations, primarily targeting companies in the U.S. healthcare sector. The units are listed under the symbol 'OHPAU' on the Nasdaq, with separate trading expected for shares and warrants under 'OHPA' and 'OHPAW'.
Orion Acquisition Corp. has successfully priced its upsized initial public offering (IPO) at $10.00 per unit, aiming to raise $360 million with 36,000,000 units. The Company, targeting the healthcare industry, is led by Kenneth Burdick and Beau Garverick, with Halle Capital Management as a partner. Units will trade on Nasdaq under the symbol OHPAU starting March 2, 2021, with expected separate trading for stock and warrants later. Credit Suisse acts as the book-running manager with a 45-day over-allotment option for underwriters.
